Àü³²´ëÇб³º´¿ø 2022 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ ½ÉÆ÷Áö¾ö : 2022-11-24±³À°ÀÏÀÚ : 2022-11-24
±³À°Àå¼Ò : Àü³²´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸Áö¿ø¼¾ÅÍ 1Ãþ ´ëȸÀǽÇ
±³À°ÁÖÁ¦ :
2022 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : È£³² Áöȸ
´ã´çÀÚ : ÃÖÈ«»ó
¿¬¶ôó : 02-3486-8736
À̸ÞÀÏ :
ksn@ksn.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 60¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
Àü¶ó³²µµ±³À°½Ã°£ : 3 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-24 ´ëȸÀÇ½Ç 14:10~14:25 A case of acute kidney injury caused by dapsone-induced methomoglobinemia in a patient with Chronic Kidney Disease ¿ÀÁÖȯ(ÀüÁÖ¿¹¼öº´¿ø)
±³À°½Ã°£ 11-24 ´ëȸÀÇ½Ç 14:25~14:40 A journey for diagnosis of hyponatremia in metastatic epithelioid mesothelioma ÀÌ¿ø±³(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 11-24 ´ëȸÀÇ½Ç 14:40~14:55 A clinical course of acute oxalate nephropathy combined with ATN(acute tubular necrosis) by ethylene glycol poisoning ÃÖÁöÀº(¿ø±¤ÀÇ´ë)
Åä·Ð 11-24 ´ëȸÀÇ½Ç 14:55~15:10 ÆгÎÅäÀÇ(ÁÖÁ¦: AKI and electrolyte disturbance) ÀÌ½Ä Á¤Á¾È¯ ÃÖÈ«»ó(ÀüºÏÀÇ´ë ¿ø±¤ÀÇ´ë Àü³²ÀÇ´ë)
ÈÞ½Ä 11-24 15:10~15:20 Break ()
±³À°½Ã°£ 11-24 ´ëȸÀÇ½Ç 15:20~15:45 ÀΰøÁö´É°ú ½ÅÀåÁúȯ ¿ÀÅ·Å(Àü³²ÀÇ´ë)
±³À°½Ã°£ 11-24 ´ëȸÀÇ½Ç 15:45~16:10 Ç÷¾×Åõ¼®È¯ÀÚ¿¡¼ ¿µ¾ç°ü¸® ±èÇü¿Ï(ÀüºÏÀÇ´ë)
Åä·Ð 11-24 ´ëȸÀÇ½Ç 16:10~16:20 ÆгÎÅäÀÇ(ÁÖÁ¦: ¸¸¼º½ÅÁúȯ ȯÀÚÀÇ »õ·Î¿î Ä¡·áÀü·«) ±èÇö¸® ¹èÀºÈñ Á¶¾Æ¿µ(Á¶¼±ÀÇ´ë Àü³²ÀÇ´ë ÀüÁÖ¿¹¼öº´¿ø)
ÈÞ½Ä 11-24 16:20~16:30 Break ()
±³À°½Ã°£ 11-24 ´ëȸÀÇ½Ç 16:30~16:50 Circulating miRNAs in extracellular vesicles related to treatment response in patients with idiopathic MN ¼±ÀοÀ(ÀüÁÖ¿¹¼öº´¿ø)
±³À°½Ã°£ 11-24 ´ëȸÀÇ½Ç 16:50~17:10 Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumor burden in mice À±¿µ¹Î(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 11-24 ´ëȸÀÇ½Ç 17:10~17:30 Dyslipidemia and CKD progression: the role of triglycerides ¼»óÇå(Àü³²ÀÇ´ë)
Åä·Ð 11-24 ´ëȸÀÇ½Ç 17:30~17:45 ÆгÎÅäÀÇ(ÁÖÁ¦: New strategies for the treatment and prevention of kidney diseases) ¾È¼±È£ ½Åº´Ã¶ °°æÇ¥(¿ø±¤ÀÇ´ë Á¶¼±ÀÇ´ë ÀüºÏÀÇ´ë)